• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种评估脊髓刺激疗法治疗成功率和成本效益成功率的简单方法。

A simple approach to outcomes assessment of the therapeutic and cost-benefit success rates for spinal cord stimulation therapy.

作者信息

Willis K Dean

机构信息

Alabama Pain Center, 964 Airport Road, Suite 1, Huntsville, AL 35801, USA.

出版信息

Anesthesiol Clin North Am. 2003 Dec;21(4):817-23. doi: 10.1016/s0889-8537(03)00089-0.

DOI:10.1016/s0889-8537(03)00089-0
PMID:14719722
Abstract

SCS was found to be cost-effective and therapeutically effective in this study for a majority of patients who had successful trial screening and were determined to be suitable candidates for SCS therapy. This is consistent with prior research if not slightly more encouraging, because typically half of the patients implanted with SCS reported 50% or more pain relief. Strikingly, most patients were considered cost successes. Overall, this study provides continued support that spinal cord stimulation offers the medical community an effective treatment for pain and reduces costs associated with the treatment of chronic intractable pain patients.

摘要

在本研究中,对于大多数成功通过试验筛查并被确定为脊髓刺激(SCS)治疗合适候选者的患者,发现SCS具有成本效益且治疗有效。这与先前的研究一致,即便不是更令人鼓舞的话,因为通常植入SCS的患者中有一半报告疼痛缓解了50%或更多。引人注目的是,大多数患者在成本方面是成功的。总体而言,这项研究持续支持了脊髓刺激为医学界提供了一种有效的疼痛治疗方法,并降低了与慢性顽固性疼痛患者治疗相关的成本。

相似文献

1
A simple approach to outcomes assessment of the therapeutic and cost-benefit success rates for spinal cord stimulation therapy.一种评估脊髓刺激疗法治疗成功率和成本效益成功率的简单方法。
Anesthesiol Clin North Am. 2003 Dec;21(4):817-23. doi: 10.1016/s0889-8537(03)00089-0.
2
Treatment of chronic pain with spinal cord stimulation versus alternative therapies: cost-effectiveness analysis.脊髓刺激与替代疗法治疗慢性疼痛的成本效益分析
Neurosurgery. 2002 Jul;51(1):106-15; discussion 115-6. doi: 10.1097/00006123-200207000-00016.
3
ICVTS on-line discussion A. Cost-benefit success rates are mandatory for SCS.国际心胸血管外科学会在线讨论A. 成本效益成功率是脊髓刺激疗法所必需的。
Interact Cardiovasc Thorac Surg. 2007 Aug;6(4):500. doi: 10.1510/icvts.2006.150185A.
4
Cost-effectiveness analysis of spinal cord stimulation in treatment of failed back surgery syndrome.
J Pain Symptom Manage. 1997 May;13(5):286-95. doi: 10.1016/s0885-3924(96)00323-5.
5
Spinal cord stimulation for refractory angina pectoris: a retrospective analysis of efficacy and cost-benefit.脊髓刺激治疗顽固性心绞痛:疗效与成本效益的回顾性分析
Coron Artery Dis. 2004 Feb;15(1):31-7. doi: 10.1097/00019501-200402000-00005.
6
The cost effectiveness of spinal cord stimulation in the treatment of pain: a systematic review of the literature.脊髓刺激治疗疼痛的成本效益:文献系统评价
J Pain Symptom Manage. 2004 Apr;27(4):370-8. doi: 10.1016/j.jpainsymman.2003.09.009.
7
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation.脊髓刺激治疗神经性或缺血性起源的慢性疼痛:系统评价与经济学评估
Health Technol Assess. 2009 Mar;13(17):iii, ix-x, 1-154. doi: 10.3310/hta13170.
8
Spinal cord stimulation for cancer-related low back pain.脊髓刺激治疗癌症相关性腰痛。
Am J Hosp Palliat Care. 2012 Mar;29(2):93-7. doi: 10.1177/1049909111410414. Epub 2011 Jun 13.
9
Spinal cord stimulation for complex regional pain syndrome: a systematic review of the clinical and cost-effectiveness literature and assessment of prognostic factors.脊髓刺激治疗复杂性区域疼痛综合征:临床及成本效益文献的系统评价与预后因素评估
Eur J Pain. 2006 Feb;10(2):91-101. doi: 10.1016/j.ejpain.2005.02.004.
10
Automated, patient-interactive, spinal cord stimulator adjustment: a randomized controlled trial.自动、患者互动式脊髓刺激器调整:一项随机对照试验。
Neurosurgery. 2003 Mar;52(3):572-80; discussion 579-80. doi: 10.1227/01.neu.0000047818.99414.fb.

引用本文的文献

1
Dorsal column stimulator applications.背柱刺激器的应用。
Surg Neurol Int. 2012;3(Suppl 4):S275-89. doi: 10.4103/2152-7806.103019. Epub 2012 Oct 31.